INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
NYSE:INSP - New York Stock Exchange, Inc. - US4577301090 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to INSP. INSP was compared to 191 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
INSP had a positive operating cash flow in the past year.
In the past 5 years INSP always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.15%, INSP is in the better half of the industry, outperforming 79.47% of the companies in the same industry.
The Return On Equity of INSP (4.74%) is better than 76.32% of its industry peers.
INSP has a Return On Invested Capital of 1.48%. This is in the better half of the industry: INSP outperforms 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.15% | ||
| ROE | 4.74% | ||
| ROIC | 1.48% |
ROA(3y)-8.44%
ROA(5y)-12.79%
ROE(3y)-10.36%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of INSP (4.37%) is better than 75.79% of its industry peers.
With a decent Operating Margin value of 1.79%, INSP is doing good in the industry, outperforming 67.37% of the companies in the same industry.
Looking at the Gross Margin, with a value of 84.77%, INSP belongs to the top of the industry, outperforming 96.32% of the companies in the same industry.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.79% | ||
| PM (TTM) | 4.37% | ||
| GM | 84.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.08%
GM growth 5Y1.1%
2. Health
2.1 Basic Checks
INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for INSP has been increased compared to 1 year ago.
Compared to 5 years ago, INSP has more shares outstanding
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 35.05 indicates that INSP is not in any danger for bankruptcy at the moment.
The Altman-Z score of INSP (35.05) is better than 97.37% of its industry peers.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 35.05 |
ROIC/WACC0.16
WACC9.29%
2.3 Liquidity
INSP has a Current Ratio of 7.84. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP's Current ratio of 7.84 is amongst the best of the industry. INSP outperforms 89.47% of its industry peers.
A Quick Ratio of 6.94 indicates that INSP has no problem at all paying its short term obligations.
INSP's Quick ratio of 6.94 is amongst the best of the industry. INSP outperforms 89.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.84 | ||
| Quick Ratio | 6.94 |
3. Growth
3.1 Past
INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 194.69%, which is quite impressive.
Looking at the last year, INSP shows a very strong growth in Revenue. The Revenue has grown by 32.51%.
The Revenue has been growing by 65.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)194.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%306.9%
Revenue 1Y (TTM)32.51%
Revenue growth 3Y75.59%
Revenue growth 5Y65.32%
Sales Q2Q%32.54%
3.2 Future
INSP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 56.27% yearly.
Based on estimates for the next years, INSP will show a quite strong growth in Revenue. The Revenue will grow by 19.49% on average per year.
EPS Next Y282.55%
EPS Next 2Y117.95%
EPS Next 3Y85.5%
EPS Next 5Y56.27%
Revenue Next Year28.5%
Revenue Next 2Y23.91%
Revenue Next 3Y21.84%
Revenue Next 5Y19.49%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 176.14 indicates a quite expensive valuation of INSP.
Based on the Price/Earnings ratio, INSP is valued a bit cheaper than 64.74% of the companies in the same industry.
INSP is valuated expensively when we compare the Price/Earnings ratio to 28.58, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 92.60, which means the current valuation is very expensive for INSP.
Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than 66.84% of the companies in the same industry.
INSP is valuated expensively when we compare the Price/Forward Earnings ratio to 24.47, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 176.14 | ||
| Fwd PE | 92.6 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INSP is valued a bit cheaper than 63.16% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, INSP is valued a bit cheaper than the industry average as 67.89% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 147.85 | ||
| EV/EBITDA | 269.13 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INSP's earnings are expected to grow with 85.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y117.95%
EPS Next 3Y85.5%
5. Dividend
5.1 Amount
No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INSPIRE MEDICAL SYSTEMS INC
NYSE:INSP (1/24/2025, 6:40:00 PM)
After market: 188.47 0 (0%)188.47
+0.88 (+0.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners110.22%
Inst Owner Change-0.06%
Ins Owners1.74%
Ins Owner Change0.16%
Market Cap5.65B
Analysts79.2
Price Target246.65 (30.87%)
Short Float %8.07%
Short Ratio4.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)503.17%
Min EPS beat(2)325.04%
Max EPS beat(2)681.29%
EPS beat(4)4
Avg EPS beat(4)424.38%
Min EPS beat(4)48.86%
Max EPS beat(4)681.29%
EPS beat(8)8
Avg EPS beat(8)239.56%
EPS beat(12)12
Avg EPS beat(12)171.69%
EPS beat(16)16
Avg EPS beat(16)136.26%
Revenue beat(2)2
Avg Revenue beat(2)1.09%
Min Revenue beat(2)0.81%
Max Revenue beat(2)1.36%
Revenue beat(4)3
Avg Revenue beat(4)0.64%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)2.28%
Revenue beat(12)10
Avg Revenue beat(12)4.38%
Revenue beat(16)14
Avg Revenue beat(16)6.05%
PT rev (1m)0.13%
PT rev (3m)6.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.68%
EPS NY rev (1m)0%
EPS NY rev (3m)78.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 176.14 | ||
| Fwd PE | 92.6 | ||
| P/S | 7.48 | ||
| P/FCF | 147.85 | ||
| P/OCF | 72.11 | ||
| P/B | 8.11 | ||
| P/tB | 8.11 | ||
| EV/EBITDA | 269.13 |
EPS(TTM)1.07
EY0.57%
EPS(NY)2.04
Fwd EY1.08%
FCF(TTM)1.27
FCFY0.68%
OCF(TTM)2.61
OCFY1.39%
SpS25.21
BVpS23.24
TBVpS23.24
PEG (NY)0.62
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.15% | ||
| ROE | 4.74% | ||
| ROCE | 1.87% | ||
| ROIC | 1.48% | ||
| ROICexc | 3.43% | ||
| ROICexgc | 3.43% | ||
| OM | 1.79% | ||
| PM (TTM) | 4.37% | ||
| GM | 84.77% | ||
| FCFM | 5.06% |
ROA(3y)-8.44%
ROA(5y)-12.79%
ROE(3y)-10.36%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.08%
GM growth 5Y1.1%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 820.89% | ||
| Cap/Sales | 5.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 426.07% | ||
| Profit Quality | 115.6% | ||
| Current Ratio | 7.84 | ||
| Quick Ratio | 6.94 | ||
| Altman-Z | 35.05 |
F-Score7
WACC9.29%
ROIC/WACC0.16
Cap/Depr(3y)567.43%
Cap/Depr(5y)508.63%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)194.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%306.9%
EPS Next Y282.55%
EPS Next 2Y117.95%
EPS Next 3Y85.5%
EPS Next 5Y56.27%
Revenue 1Y (TTM)32.51%
Revenue growth 3Y75.59%
Revenue growth 5Y65.32%
Sales Q2Q%32.54%
Revenue Next Year28.5%
Revenue Next 2Y23.91%
Revenue Next 3Y21.84%
Revenue Next 5Y19.49%
EBIT growth 1Y127.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year130.71%
EBIT Next 3Y60.33%
EBIT Next 5Y51.62%
FCF growth 1Y379.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1223.79%
OCF growth 3YN/A
OCF growth 5YN/A